Tirzepatide
A Study to Evaluate ALN-2232 in Participants With Obesity
Eli Lilly · Phase 1/2 · Recruiting · Enrollment 156
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Tirzepatide
Eli Lilly · Phase 1/2 · Recruiting · Enrollment 156
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.